PTGS2 and depressive symptom measurement: Previous studies have demonstrated that COX‐2 and PGE2 are upregulated in a rat model of depression, and inhibition of the COX‐2/PGE2 pathway can mitigate the inflammatory response in the hippocampus and effectively alleviate depressive behaviors (Song et al. 2018).